However, the importance of the MAPK/ERK pathway in human HCC has been neglected for a long time, mainly because mutations in RAS and RAF have not been frequently detected, found in less than 5% of HCC cases [16]. The gene discussed is MAPK1; the disease is hepatocellular carcinoma.